News
Eli Lilly's Mounjaro shows significant cardiovascular benefits in a major trial enhancing treatment options for type 2 ...
James Van Der Beek and Guardant are partnering for a campaign focused on colorectal cancer. Guardant Health announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback